Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability

Heneghan, L. J., Tsang, A., Dimino, C., Khandji, A. G., Panigrahi, S. K., & Page-Wilson, G. (2023). Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability. The Journal of Clinical Endocrinology & Metabolism, 109(2), e667–e674. https://doi.org/10.1210/clinem/dgad545
Authors:
Liam J Heneghan
Amanda Tsang
Cara Dimino
Alexander G Khandji
Sunil K Panigrahi
Gabrielle Page-Wilson
Affiliated Authors:
Liam J Heneghan
Amanda Tsang
Cara Dimino
Alexander G Khandji
Sunil K Panigrahi
Gabrielle Page-Wilson
Columbia Affiliation:
Subjects:
Hyperprolactinemia (MeSH)
Pituitary Neoplasms (MeSH)
Prolactinoma (MeSH)
Galactorrhea (MeSH)
Amenorrhea (MeSH)
Indoles (MeSH)
Author Keywords:
clinical trial
dopamine agonist
hyperprolactinemia
prolactinoma
ropinirole
elink
Publication Type:
Article
Unique ID:
10.1210/clinem/dgad545
PMID:
37715962
DOI:
10.1210/clinem/dgad545
Journal:
Journal of Clinical Endocrinology and Metabolism
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: